Parkinson's disease: kinase busters to the rescue? Commentary

Affiliations

Comment

Stephen D Skaper. CNS Neurol Disord Drug Targets. 2011 Feb.

. 2011 Feb;10(1):1.

doi: 10.2174/187152711794488593.

¹ Department of Pharmacology and Anesthesiology, University of Padova, Padova, Italy. stephen.skaper@unipd.it

No abstract available

Comment on

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.
Lee BD, Shin JH, VanKampen J, Petrucelli L, West AB, Ko HS, Lee YI, Maguire-Zeiss KA, Bowers WJ, Federoff HJ, Dawson VL, Dawson TM. Lee BD, et al. Nat Med. 2010 Sep;16(9):998-1000. doi: 10.1038/nm.2199. Epub 2010 Aug 22. Nat Med. 2010. PMID: 20729864 Free PMC article.